Bone Biologics enters revised employment agreement with CFO, base salary $200K

Bone Biologics Corp

Employment agreement effective Jan 3, 2022; at-will; base salary $200,000.
Annual target bonus of 25% of base salary, subject to board-set objectives.
Stock option grant of 25,000 shares with 2-year maturity at market price.
CFO Deina H. Walsh has served since Nov 2014; new agreement updates terms.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.